semaglutide and dialysis Kidney care is entering a whole new era 💙 With the 2025 FDA approval of Ozempic (semaglutide) to help slow chronic kidney disease in people with type 2 diabetes, patients now have The Heart - 🔴Semaglutide in

Weight loss was accompanied by improvements in cardiometabolic risk factors including fasting glucose, insulin levels, lipid profiles, and blood pressure

Diclofenac pretreatment modulates exercise-induced inflammation in skeletal muscle of rats through the TLR4/NF-B pathway

For some patients, clinics may also combine peptides with other medical weightloss tools when clinically appropriate

In addition, they can be used in adolescents from 12 years of age with obesity (BMI of 30 kg/m2 or more) who weigh more than 60 kg

And in the increasingly common Zepbound vs Wegovy discussion, the best answer is never "which one is more popular," but "which one is more appropriate for this patient, with this history, under clinician supervision." Ready to Find Clarity on Your Weight Loss Journey

Heres a general framework for microdosing: Step-by-Step Microdosing Guide Consultation : Start by consulting with a healthcare provider, ideally one who understands weight management and GLP-1 medications